drugset / Trial / NCT00143741
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to identify subjects who are highly sensitized with antibodies. It is difficult for these patients to find suitable kidneys. We propose to treat such patients to decrease the antibodies in such a way, that it may become possible to safely transplant kidneys into them.
Timeline
- Start
- 2005-05
- Primary completion
- 2010-12
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | Oral |